Vaccins antiviraux < Vaccins atténués < Vaccins comestibles

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by Vaccins atténués

Number of relevant bibliographic references: 28.
[20-40] [0 - 20][0 - 28]

Ident.	Authors (with country if any)	Title
003751 (2007)	Seong-Jun Park [Corée du Sud] ; Dae-Sub Song ; Gun-Woo Ha ; Bong-Kyun Park	Cloning and further sequence analysis of the spike gene of attenuated porcine epidemic diarrhea virus DR13.
003E50 (2006)	Koji Ishii [Japon] ; Hideki Hasegawa [Japon] ; Noriyo Nagata [Japon] ; Tetsuya Mizutani [Japon] ; Shigeru Morikawa [Japon] ; Tetsuro Suzuki [Japon] ; Fumihiro Taguchi [Japon] ; Masato Tashiro [Japon] ; Toshitada Takemori [Japon] ; Tatsuo Miyamura [Japon] ; Yasuko Tsunetsugu-Yokota [Japon]	Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs
004659 (2005)	Konrad Stadler ; Anjeanette Roberts ; Stephan Becker ; Leatrice Vogel ; Markus Eickmann ; Larissa Kolesnikova ; Hans-Dieter Klenk ; Brian Murphy ; Rino Rappuoli ; Sergio Abrignani ; Kanta Subbarao	SARS vaccine protective in mice.
004770 (2005)	Sagar U. Kapadia [États-Unis] ; John K. Rose ; Elaine Lamirande ; Leatrice Vogel ; Kanta Subbarao ; Anjeanette Roberts	Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine.
004C35 (2005)	Derrick Louz [Pays-Bas] ; Hans E. Bergmans [Pays-Bas] ; Birgit P. Loos [Pays-Bas] ; Rob C. Hoeben [Pays-Bas]	Cross‐species transfer of viruses: implications for the use of viral vectors in biomedical research, gene therapy and as live‐virus vaccines
005231 (2004)	Alexander Bukreyev [États-Unis] ; Elaine W. Lamirande ; Ursula J. Buchholz ; Leatrice N. Vogel ; William R. Elkins ; Marisa St Claire ; Brian R. Murphy ; Kanta Subbarao ; Peter L. Collins	Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS.
005232 (2004)	Ar Foxwell [Australie] ; Aw Cripps [Australie]	Mucosal immunisation and immunoprophylaxis as potential strategies for prevention of SARS
006047 (2003)	Elena Armandola [Allemagne]	Conference report - II. Investigating new vaccines: SARS. Highlights from the Viral Vaccine Meeting; October 25-28, 2003; Barcelona, Spain.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i -k "Vaccins atténués" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i  \
                -Sk "Vaccins atténués" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    MeshFr.i
   |clé=    Vaccins atténués
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021